Format

Send to

Choose Destination
World J Gastroenterol. 2016 Aug 14;22(30):6776-99. doi: 10.3748/wjg.v22.i30.6776.

New advances in targeted gastric cancer treatment.

Author information

1
Daniela Cornelia Lazăr, Adrian Goldiş, Department of Gastroenterology and Hepatology, University of Medicine and Pharmacy, "Victor Babeş", 300041 Timişoara, Timis County, Romania.

Abstract

Despite a decrease in incidence over past decades, gastric cancer remains a major global health problem. In the more recent period, survival has shown only minor improvement, despite significant advances in diagnostic techniques, surgical and chemotherapeutic approaches, the development of novel therapeutic agents and treatment by multidisciplinary teams. Because multiple genetic mutations, epigenetic alterations, and aberrant molecular signalling pathways are involved in the development of gastric cancers, recent research has attempted to determine the molecular heterogeneity responsible for the processes of carcinogenesis, spread and metastasis. Currently, some novel agents targeting a part of these dysfunctional molecular signalling pathways have already been integrated into the standard treatment of gastric cancer, whereas others remain in phases of investigation within clinical trials. It is essential to identify the unique molecular patterns of tumours and specific biomarkers to develop treatments targeted to the individual tumour behaviour. This review analyses the global impact of gastric cancer, as well as the role of Helicobacter pylori infection and the efficacy of bacterial eradication in preventing gastric cancer development. Furthermore, the paper discusses the currently available targeted treatments and future directions of research using promising novel classes of molecular agents for advanced tumours.

KEYWORDS:

Chemotherapy; Clinical trials; Gastric cancer; Helicobacter pylori infection; New treatment advances; Targeted therapy

PMID:
27570417
PMCID:
PMC4974579
DOI:
10.3748/wjg.v22.i30.6776
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Baishideng Publishing Group Inc. Icon for PubMed Central
Loading ...
Support Center